Age-related macular degeneration: a perspective on genetic studies.

Age-related macular degeneration: a perspective on genetic studies.

AIM: Age-related macular degeneration (AMD) is a common macular disease in the developed world and recent studies have shown that specific genes may be associated with it and may contribute to a higher risk of developing AMD. OBJECTIVE: Our objective was to review systematically recent publications...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Patel, N, Adewoyin, T, Chong, N
Format:	Journal article
Język:	English
Wydane:	2008

Podobne zapisy

Pulsatile ocular blood flow in asymmetric age-related macular degeneration.
od: Sandhu, R, i wsp.
Wydane: (2007)

Computerized model of cost-utility analysis for treatment of age-related macular degeneration.
od: Fletcher, E, i wsp.
Wydane: (2008)

Estimation of systemic complement C3 activity in age-related macular degeneration.
od: Sivaprasad, S, i wsp.
Wydane: (2007)

The complement system and age-related macular degeneration.
od: Sivaprasad, S, i wsp.
Wydane: (2006)

Genetic Insights into Age-Related Macular Degeneration
od: Bhumika, i wsp.
Wydane: (2024-07-01)

Genetic polymorphisms associated with Age-related macular degeneration
od: Zulvikar Syambani Ulhaq
Wydane: (2020-02-01)

Genetic Risk in Families with Age-Related Macular Degeneration
od: Anita de Breuk, MD, i wsp.
Wydane: (2021-12-01)

Identification of anti-retinal antibodies in patients with age-related macular degeneration.
od: Morohoshi, K, i wsp.
Wydane: (2012)

Serum elastin-derived peptides in age-related macular degeneration.
od: Sivaprasad, S, i wsp.
Wydane: (2005)

A pilot study on the combination treatment of reduced-fluence photodynamic therapy, intravitreal ranibizumab, intravitreal dexamethasone and oral minocycline for neovascular age-related macular degeneration.
od: Sivaprasad, S, i wsp.
Wydane: (2011)

Radiotherapy for neovascular age-related macular degeneration.
od: Evans, JR, i wsp.
Wydane: (2010)

Drusen classification in bilateral drusen and fellow eye of exudative age-related macular degeneration.
od: Hamada, S, i wsp.
Wydane: (2006)

Should avastin be used to treat age-related macular degeneration in the NHS?--No.
od: Chong, N
Wydane: (2009)

Age-related macular degeneration
od: Querques G, i wsp.
Wydane: (2011-05-01)

Age-related macular degeneration
od: Wanjiku Mathenge
Wydane: (2014-12-01)

Metabolomics and Age-Related Macular Degeneration
od: Connor N. Brown, i wsp.
Wydane: (2018-12-01)

A Pattern of Age-related Macular Degeneration
od: Suprada Pokhrel, i wsp.
Wydane: (2009-07-01)

Genetic factors associated with the development of age-related macular degeneration
od: Olga Sergejeva, i wsp.
Wydane: (2016-01-01)

Genetic risk factors and age-related macular degeneration (AMD)
od: Maryam Mousavi, i wsp.
Wydane: (2013-10-01)

Update on the role of genetics in the onset of age-related macular degeneration
od: Francis PJ, i wsp.
Wydane: (2011-08-01)

Macular thickness varies with age-related macular degeneration genetic risk variants in the UK Biobank cohort
od: Rebecca A. Kaye, i wsp.
Wydane: (2021-12-01)

Serum autoantibody biomarkers for age-related macular degeneration and possible regulators of neovascularization.
od: Morohoshi, K, i wsp.
Wydane: (2012)

THE PROGNOSTIC VALUE OF PHARMACOLOGICAL AND GENETIC TESTING IN MEDICAL THERAPY OF AGE-RELATED MACULAR DEGENERATION
od: N. A. Bakunina, i wsp.
Wydane: (2018-10-01)

Stem cells for age-related macular degeneration
od: L.K. Moshetova, i wsp.
Wydane: (2019-09-01)

Characterizing Macular Neovascularization in Myopic Macular Degeneration and Age-Related Macular Degeneration Using Swept Source OCTA
od: Sayah DN, i wsp.
Wydane: (2023-12-01)

Genetics and Age-Related Macular Degeneration: A Practical Review for Clinicians
od: Julia Nguyen, i wsp.
Wydane: (2024-02-01)

Genetics and age-related macular degeneration: a practical review for the clinician
od: Schwartz SG, i wsp.
Wydane: (2016-07-01)

Optical coherence tomography in neovascular age-related macular degeneration
od: Chong, V
Wydane: (2012)

Pharmacogenetics and Age-Related Macular Degeneration
od: Stephen G. Schwartz, i wsp.
Wydane: (2011-01-01)

Choriocapillaris in Age-Related Macular Degeneration
od: Giovanni Neri, i wsp.
Wydane: (2024-08-01)

Nanotechnology for Age-Related Macular Degeneration
od: Bo Yang, i wsp.
Wydane: (2021-11-01)

Age-Related Macular or Retinal Degeneration?
od: Michalina Gałuszka, i wsp.
Wydane: (2023-05-01)

Pharmacotherapy for Age-Related Macular Degeneration
od: Hamid Ahmadieh
Wydane: (2008-12-01)

Neuroprotection for Age-Related Macular Degeneration
od: Jonathan B. Lin, MD, PhD, i wsp.
Wydane: (2022-12-01)

Age-related macular degeneration and the aging eye
od: Rita Ehrlich, i wsp.
Wydane: (2008-09-01)

Targeting the Complement Cascade for Treatment of Dry Age-Related Macular Degeneration
od: Prem N. Patel, i wsp.
Wydane: (2022-08-01)

Systemic complement activation in age-related macular degeneration.
od: Hendrik P N Scholl, i wsp.
Wydane: (2008-07-01)

Importance of genetic polymorphisms in the response to age-related macular degeneration treatment
od: Carlos Eduardo dos Reis Veloso, i wsp.
Wydane: (2012-06-01)

Epistatic interactions of genetic loci associated with age-related macular degeneration
od: Christina Kiel, i wsp.
Wydane: (2021-06-01)

Genetics of Unilateral and Bilateral Age-Related Macular Degeneration Severity Stages.
od: Tina Schick, i wsp.
Wydane: (2016-01-01)